Akèy › Ateroskleroz › Utah
Etid klinik pou Ateroskleroz nan Utah
8 etid pou Ateroskleroz ap chèche patisipan nan sit nan Utah.
Vil nan Utah
Tèks ofisyèl etid la (Anglè)
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
- Ogden Clinic - Canyon View, Ogden
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07783802Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
- Intermountain Medical Center, Murray
- Ogden Clinic - Canyon View, Ogden
- Advanced Research Institute, Ogden
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 24, 2026 · NCT07157774Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
- Boeson Research, Provo
- Velocity Clinical Research - Salt Lake City, West Jordan
Ap rekriteFaz 3
Laj 45 a 99 · Tout sèks · Mizajou Sep 22, 2026 · NCT07037433A Study to See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With Elevated Lp(a) Who Have Had Heart Events or Are at High Risk
- Intermountain Medical Center, Murray
Ap rekriteFaz 3
Laj 45 a 80 · Tout sèks · Mizajou Sep 22, 2026 · NCT07613294A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
- Research Site, Bountiful
- Research Site, Ogden
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Aug 24, 2026 · NCT07000357Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD
- Intermountain Medical Center, Murray
Ap rekriteFaz 3
Laj 18 a 80 · Tout sèks · Mizajou Aug 7, 2026 · NCT06813911Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes
- VA Salt Lake City Health Care System, Salt Lake City, UT, Salt Lake City
Ap rekriteFaz 4
Laj 18 ak plis · Tout sèks · Mizajou Dec 17, 2025 · NCT02915198A Pragmatic INitiative for LDL-C Management by a CLinical Pharmacist-Led Team Among Atherosclerotic CardiovascUlar DisEase Patients
- Intermountain Healthcare Hospitals and Clinics, Salt Lake City
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou May 6, 2025 · NCT06571162Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.